M. Correia

Aryl Hydrocarbon Receptor and Cysteine Redox Dynamics Underlie (Mal)adaptive Mechanisms to Chronic Intermittent Hypoxia in Kidney Cortex

X. Coumoul, R. Barouki, J. Serpa, 2021, Antioxidants.

Efavirenz biotransformation as an up-stream event of mood changes in HIV-infected patients.

N. Grilo, A. Antunes, U. Caixas, 2016, Toxicology letters.

First evidence of aryl hydrocarbon receptor as a druggable target in hypertension induced by chronic intermittent hypoxia.

X. Coumoul, R. Barouki, E. Monteiro, 2020, Pharmacological research.

Mercapturate Pathway in the Tubulocentric Perspective of Diabetic Kidney Disease

A. Antunes, E. Monteiro, S. Pereira, 2019, Nephron.

Cysteine as a Multifaceted Player in Kidney, the Cysteine-Related Thiolome and Its Implications for Precision Medicine

J. B. Vicente, J. Serpa, Patrícia Branco, 2022, Molecules.

AHR canonical pathway: in vivo findings to support novel antihypertensive strategies.

E. Monteiro, S. Pereira, J. Morello, 2021, Pharmacological research.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

S-thiolated protein profile to assess the redox-modulation effects of antiretroviral drugs

M. Correia, 2016 .

A Mechanistic-Based and Non-invasive Approach to Quantify the Capability of Kidney to Detoxify Cysteine-Disulfides.

J. B. Vicente, A. Antunes, E. Monteiro, 2021, Advances in experimental medicine and biology.

Clinical Practice: Mini-Review

A. Antunes, E. Monteiro, S. Pereira, 2019 .

Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence

E. Monteiro, S. Pereira, T. Rodrigues, 2021, Journal of Molecular Medicine.

Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanisms

J. Serpa, N. Grilo, A. Antunes, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.